# THERAVANCE BIOPHARMA INC (TBPH) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: G8807B106
Page URL: https://superinvestorclub.com/stock/TBPH
Last updated: 2026-08-29T13:48:07.897Z

## Summary

As of the most recent 13F filing period, THERAVANCE BIOPHARMA INC (TBPH) is held by 0 tracked superinvestors with an aggregate position value of $0 representing 0 shares.

## Top institutional holders (0)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|

## Ownership history (quarter-over-quarter)

- 2023-03-31: 1 holders, $113.0M aggregate, 010419226 shares
- 2023-06-30: 1 holders, $76.8M aggregate, 07419226 shares
- 2023-09-30: 1 holders, $64.0M aggregate, 07419226 shares
- 2023-12-31: 1 holders, $83.4M aggregate, 07419226 shares
- 2024-03-31: 1 holders, $59.1M aggregate, 06594126 shares
- 2024-06-30: 1 holders, $35.6M aggregate, 04200021 shares

## Recent congressional trades (2)

- 2025-03-24: George Whitesides (D-CA) sale $15,001 - $50,000
- 2025-03-24: George  Whitesides (Democrat-CA) sale $15,001 - $50,000

## Recent insider transactions (0)


## Citation

When citing, use: "THERAVANCE BIOPHARMA INC (TBPH) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/TBPH), aggregating SEC 13F, Form 4, and congressional disclosures."